Adjunctive Treatment of Periodontal Defects Using Fibroblast Growth Factor 2: A Review of Case Reports with Long-term Follow-up
Journal of Dental School,
Vol. 43 No. 3 (2025),
30 July 2025
,
Page 164-172
https://doi.org/10.22037/jds.v43i3.46759
Abstract
Objective(s): Application of fibroblast growth factor 2 (FGF2) as an adjunctive treatment in periodontal regeneration is a treatment modality. Several recent case reports describe the application of FGF-2 in different periodontal defects with detailed information and long-term follow-ups. The aim of this review was to assess the effect of FGF-2 on periodontal regeneration and patient quality of life in cases with long-term follow-up. Methods: An electronic search was performed in PubMed Central, Scopus, and web of science databases from 1990 until December 2023. The search included all case reports in which FGF2 was used for periodontal defect treatment with long-term follow-up. Case series which described detailed data of their cases were also evaluated. Ten articles including 12 patients, 23 teeth, and 25 defects were included in the study. Results: Most of the treated defects were infrabony defects (84%), followed by furcation defects (12%). Probing depth (PD) reduction and clinical attachment loss (CAL) gain were seen in all defects and evidence of bone fill was documented. All cases had a follow-up duration of at least 12 months, with the greatest follow-up time of 9 years. Conclusion: Adjunctive treatment of periodontal defects using FGF-2 is an effective and stable treatment modality that provides patients’ satisfaction. However, more studies in this field are recommended.
- Fibroblast Growth Factor 2
- Periodontal Regeneration
- Periodontal Bone Defect
How to Cite
References
Cortellini P, Tonetti MS. Clinical concepts for regenerative therapy in intrabony defects. Periodontol 2000;2015;68:282–307. doi: 10.1111/prd.12048
Smith PC, Martínez C, Cáceres M, Martínez J. Research on growth factors in periodontology. Periodontology 2000;2015;67:234–50. doi: 10.1111/prd.12068
Fujihara C, Kanai Y, Masumoto R, Kitagaki J, Matsumoto M, Yamada S, et al. Fibroblast growth factor-2 inhibits CD40-mediated periodontal inflammation. J Cell Physiol 2019;234:7149–60. doi: 10.1002/jcp.27469
Atarbashi-Moghadam F, Azadi A, Nokhbatolfoghahaei H, Taghipour N. Effect of simultaneous and sequential use of TGF-β1 and TGF-β3 with FGF-2 on teno/ligamentogenic differentiation of periodontal ligament stem cells. Arch Oral Biol. 2024;162:105956. doi: 10.1016/j.archoralbio.2024.105956.
Kono K, Maeda H, Fujii S, Tomokiyo A, Yamamoto N, Wada N, et al. Exposure to transforming growth factor-β1 after basic fibroblast growth factor promotes the fibroblastic differentiation of human periodontal ligament stem/progenitor cell lines. Cell Tissue Res 2013;352:249–63. doi: 10.1007/s00441-012-1543-0
Atarbashi-Moghadam F, Mahmoudian A, Taghipour N, Hakimiha N, Azadi A, Nokhbatolfoghahaei H. Enhancement of the angiogenic differentiation in the periodontal ligament stem cells using fibroblast growth factor 2 and photobiomodulation: An in vitro investigation. Photochem Photobiol. 2025;101(3):660-72. doi: 10.1111/php.14032
Nagayasu-Tanaka T, Anzai J, Takedachi M, Kitamura M, Harada T, Murakami S. Effects of combined application of fibroblast growth factor (FGF)-2 and carbonate apatite for tissue regeneration in a beagle dog model of one-wall periodontal defect. Regen Ther. 2023;23:84-93. doi: 10.1016/j.reth.2023.04.002
Kitamura M, Nakashima K, Kowashi Y, Fujii T, Shimauchi H, Sasano T, et al. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS One. 2008;3(7):e2611. doi: 10.1371/journal.pone.0002611
Kitamura M, Akamatsu M, Machigashira M, Hara Y, Sakagami R, Hirofuji T, et al. FGF-2 stimulates periodontal regeneration: Results of a multi-center randomized clinical trial. J Dent Res. 2011;90:35-40. doi: 10.1177/0022034510384616
Takayama SI, Murakami S. Efficacy of FGF-2 in Periodontal Regeneration in a Case of Severe Intrabony Defect and Furcation Involvement With 15-Month Follow-Up. Clin Adv Periodontics. 2021;11(2):74-79. doi: 10.1002/cap.10127
Ogawa Y, Maekawa S, Imamura K, Ishikawa T. Supra-Alveolar Periodontal Tissue Reconstruction in a Case with Severe Periodontitis: Case Report with a 2-Year Follow-up. Int J Periodontics Restorative Dent. 2023;43(2):212-21. doi: 10.11607/prd.6241
Yoshinuma N, Koshi R, Kawamoto K, Idesawa M, Sugano N, Sato S. Periodontal regeneration with 0.3% basic fibroblast growth factor (FGF-2) for a patient with aggressive periodontitis: a case report. J Oral Sci. 2016;58(1):137-40. doi: 10.2334/josnusd.58.137.
Iwaki J, Imamura K, Tanaka K, Sugito H, Saito A. Treatment of Stage III Grade C Periodontitis with Periodontal Regenerative Therapy including Guided Tissue Regeneration (GTR) and Recombinant Human Fibroblast Growth Factor (rhFGF)-2: A Case Report. Bull Tokyo Dent Coll. 2023;63(4):189-98. doi: 10.2209/tdcpublication.2022-0017
Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218-35. doi: 10.1016/j.jclinepi.2017.04.026.
Nakane-Koyachi S, Imamura K, Saito A. Treatment of Chronic Periodontitis with Periodontal Surgery Including Regenerative Therapy Using Recombinant Human Fibroblast Growth Factor-2 and Papilla Preservation Technique: A Case Report with a Two-year Follow-up. Bull Tokyo Dent Coll. 2022;63(2):95-103. doi: 10.2209/tdcpublication.2021-0048.
Bizenjima T, Irokawa D, Tanaka K, Saito A, Tomita S. Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Patient with Chronic Periodontitis: An 18-month Follow-up Report. Bull Tokyo Dent Coll. 2021;62(2):107-17. doi: 10.2209/tdcpublication.2020-0034
Matsugami D, Aoki H, Saito A. Surgical Periodontal Therapy with Recombinant Human Fibroblast Growth Factor-2 in Treatment of Chronic Periodontitis: A Case Report with 2-year Follow-up. Bull Tokyo Dent Coll. 2021;62(2):127-34. doi: 10.2209/tdcpublication.2020-0045.
Yoshida W, Takeuchi T, Imamura K, Seshima F, Saito A, Tomita S. Treatment of Chronic Periodontitis with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Wide Intrabony Defects:12-month Follow-up Case Series. Bull Tokyo Dent Coll. 2020;61(4):231-241. doi: 10.2209/tdcpublication.2019-0050
Ninomiya M, Azuma T, Kido J, Murakami Sh, Nagata T. Successful case of periodontal tissue repair with fibroblast growth factor-2: long-term follow-up and comparison to enamel matrix derivative. Clin Adv Periodontics 2013;3:215-21. doi: 10.1902/cap.2012.120014
Nagahara T, Takeda K, Inoue S, Wada K, Shiba H. Successful regenerative response of a severe bone defect in a right lower central incisor affected by a cemental tear. Clin Case Rep. 2022;10(11):e6472. doi: 10.1002/ccr3.6472
Gamal AY, Mailhot JM. The effects of EDTA gel conditioning exposure time on periodontitis-affected human root surfaces: surface topography and PDL cell adhesion. J Int Acad Periodontol. 2003;5(1):11-22.
Song A, Cai J, Pan K, Yang P. Pre-existing root cementum may promote cementoblast differentiation of human periodontal ligament cells. Cell Prolif. 2012;45(3):249-58. doi: 10.1111/j.1365-2184.2012.00815.x
Pei X. New surgery approaches preserving entire papilla to treat isolated interdental intrabony defects: A narrative review. Clin Exp Dent Res. 2021;7(5):719-25. doi: 10.1002/cre2.410
Shah EB, Modi BB, Shah MA, Dave DH. Patient centered outcomes in periodontal treatment-an evidence based approach. J Clin Diag Res. 2017; 11(4): ZE05-ZE07. doi: 10.7860/JCDR/2017/24260.9631
- Abstract Viewed: 115 times
- PDF Downloaded: 106 times